1. Home
  2. ITOS vs PDLB Comparison

ITOS vs PDLB Comparison

Compare ITOS & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • PDLB
  • Stock Information
  • Founded
  • ITOS 2011
  • PDLB 1960
  • Country
  • ITOS United States
  • PDLB United States
  • Employees
  • ITOS N/A
  • PDLB N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • PDLB
  • Sector
  • ITOS Health Care
  • PDLB
  • Exchange
  • ITOS Nasdaq
  • PDLB Nasdaq
  • Market Cap
  • ITOS 270.7M
  • PDLB 285.3M
  • IPO Year
  • ITOS 2020
  • PDLB 2017
  • Fundamental
  • Price
  • ITOS $7.19
  • PDLB $12.54
  • Analyst Decision
  • ITOS Strong Buy
  • PDLB
  • Analyst Count
  • ITOS 3
  • PDLB 0
  • Target Price
  • ITOS $26.00
  • PDLB N/A
  • AVG Volume (30 Days)
  • ITOS 334.2K
  • PDLB 47.7K
  • Earning Date
  • ITOS 03-05-2025
  • PDLB 04-29-2025
  • Dividend Yield
  • ITOS N/A
  • PDLB N/A
  • EPS Growth
  • ITOS N/A
  • PDLB 212.14
  • EPS
  • ITOS N/A
  • PDLB 0.46
  • Revenue
  • ITOS $35,000,000.00
  • PDLB $82,359,000.00
  • Revenue This Year
  • ITOS N/A
  • PDLB $10.97
  • Revenue Next Year
  • ITOS $121.70
  • PDLB $8.59
  • P/E Ratio
  • ITOS N/A
  • PDLB $27.50
  • Revenue Growth
  • ITOS 177.89
  • PDLB 10.53
  • 52 Week Low
  • ITOS $6.67
  • PDLB $7.89
  • 52 Week High
  • ITOS $18.75
  • PDLB $13.97
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 48.18
  • PDLB 36.89
  • Support Level
  • ITOS $6.73
  • PDLB $12.50
  • Resistance Level
  • ITOS $7.32
  • PDLB $12.72
  • Average True Range (ATR)
  • ITOS 0.38
  • PDLB 0.21
  • MACD
  • ITOS 0.03
  • PDLB -0.06
  • Stochastic Oscillator
  • ITOS 53.06
  • PDLB 4.04

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

Share on Social Networks: